Neoadjuvant mFOLFOX6 Chemotherapy Combined With Anti-PD-1 Therapy in MSS/pMMR Locally Advanced Rectal Cancer (FIRM02 Study)

NCT07381400 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

128

Enrollment

OTHER

Sponsor class

Conditions

Rectal Cancer

Interventions

DRUG: mFOLFOX6
DRUG: Serplulimab

Sponsor

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine